• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Prostate Cancer Endpoints Information

The Food and Drug Administration (FDA) is holding a public workshop on endpoints for prostate cancer. Issues identified in the workshop will be further discussed before the Oncologic Drugs Advisory Committee (ODAC) and thereafter will be detailed in FDA Guidance Documents.


Date: June 21-22, 2004, from 8:00 a.m. to 5:00 p.m.


Address: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814, (301) 897-9400

Metro Access: Closest Metro stop is Medical Center on the RED line. Shuttle Service provided by the Bethesda Marriott from the Medical Center Metro stop approximately every hour and half hour between 6:30 am - 10:30 am and 3:30 pm - 8:30 pm. Outside these times, there is a taxi stand available at the Bethesda Metro stop.

Registration: No registration is required to attend the meeting. Seating will be available for 300 people on a first-come, first-served basis.


For further information, contact:

Dianne Spillman, Division of Oncology Drug Products (HFD-150), Center for Drug Evaluation and Research, Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857.  Phone: 301-594-5746.  Email: spillmand@cder.fda.gov